Amikacin/Cefepime

阿米卡星/头孢吡肟

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmikacin/Cefepime
Drug Alias NameAmikacin+Cefepime阿米卡星+头孢吡肟头孢吡肟+阿米卡星Cefepime/Amikacin头孢吡肟/阿米卡星 +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsBacterial penicillin-binding protein inhibitorsCell wall inhibitors
Targets30S ribosomal subunitBacterial penicillin-binding protein
Therapy Area/IndicationsFebrile NeutropeniaHealthcare-Associated Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Cefepime HydrochlorideAmikacin Sulfate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVenus Remedies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsFebrile NeutropeniaHealthcare-Associated Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeJ01RA06
Related LinksN/A